JAZZ $119.77 1.72 (1.46%)Jazz Pharmaceuticals PLC
NASDAQ: JAZZ $7 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 21%. 1 Year Return 23%. 2019 YTD Return 4%. Negative 5 year, 1 year & YTD returns. You may want to avoid this one until things turn around. Check out some Uptrending symbols instead. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)
Market Cap 7 Billion
Jazz Pharmaceuticals is an Ireland-domiciled specialty pharmaceutical firm focused primarily on treatments for orphan drug indications. Jazz's product portfolio includes lead drug Xyrem for narcolepsy, Erwinaze for acute lymphoblastic leukemia, Defitelio for severe veno-occlusive disease, and Vyxeos for acute myeloid leukemia.
EPS 4.62 P/E Ratio 17.26
Previous Tue, Aug 6, 2019
Latest Tue, Nov 5, 2019 (In 19 days)
Pay Date --
Dec 24, 2018
Nov 2, 2018
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.